Expression of catecholaminergic genes in the midbrain and prepulse inhibition in rats with a genetic catatonia

The GC rat strain (from the words “genetic” and “catatonia”) was created by selection for predisposition to passive-defensive reaction of catatonic freezing in response to stressing stimuli. Rats of the GC strain have previously demonstrated a number of biochemical and behavioral properties similar to those of patients with schizophrenia and depression. Prepulse inhibition (PPI) is widely explored as an important indicator, a decrease of which may be indicative of psychopathology, including schizophrenia. It has been established that the brain noradrenergic system influences the manifestation of PPI, in particular through the activation of central alpha-adrenoreceptors. Also known is the association between PPI and expression of catechol-O-methyltransferase. This study focuses on the reaction of prepulse inhibition in rats of the inbred GC strain, being considered as a hypothetical model of schizophrenia, as well as on the relation of prepulse inhibition to mRNA expression of tyrosine hydroxylase, catechol-O-methyltransferase, alpha1A- and alpha2Aadrenergic receptors in the midbrain of GC rats. For the first time, a decrease of PPI in GC rats compared with WAG rats was shown, both with a prepulse power of 75 dB and at 85 dB, which may indicate a violation of filtration of sensorimotor information into the central nervous system in GC rats. Real-time PCR showed a decrease in mRNA level of Adra1A in intact rats with genetic catatonia when compared to control WAG rats. There was observed no correlation between the expression of mRNA of the Adra1A, Adra2A, Th, and Comt genes in the midbrain and the PPI reaction in GC rats. The reduction of prepulse inhibition in GC rats indicates functional similarity of this genetic model of schizophrenic psychopathology with a prototype.

genetic catatonia, prepulse inhibition, midbrain, gene expression, alpha-adrenoreceptors, catechol-O-methyltransferase, tyrosine hydroxylase

1. Alekhina T.A., Gilinsky M.A., Kolpakov V.G. Catecholamines level in the brain of rats with a genetic predisposition to catatonia. Biogenic Amines. 1994;10(5):443-449.

2. Alsene K.M., Carasso B.S., Connors E.E., Bakshi V.P. Disruption of prepulse inhibition after stimulation of central but not peripheral a-1 adrenergic receptors. Neuropsychopharmacology. 2006;31(10):2150-2161. DOI 10.1038/sj.npp.1300989.

3. Barykina N.N., Alekhina T.A., Chuguy V.F., Petrenko O.I., Popova N.K., Kolpakov V.G. Negative correlation between cataleptic freezing and prepulse inhibition of the startle reflex in rats. Rossiy-skiy fiziologicheskiy zhurnal im. I.M. Sechenova = I.M. Sechenov Physiological Journal. 2002;88(11):1388-1393. (in Russian)

4. Barykina N.N., Chepkasov I.L., Alekhina T.A., Kolpakov V.G. Breeding of Wistar rats for predesposition to catalepsy. Genetika = Genetics (Moscow). 1983;19(12):2014-2021. (in Russian)

5. Carasso B.S., Bakshi V.P., Geyer M.A. Disruption in prepulse inhibition after alpha-1 adrenoceptor stimulation in rats. Neuropharmacology. 1998;37(3):401-404. https://doi.org/10.1016/S0028-3908(98) 00051-3.

6. Doze V.A., Handel E.M., Jensen K.A., Darsie B., Luger E.J., Hasel-ton J.R., Talbot J.N., Rorabaugh B.R. Alpha(1A)- and alpha(1B)-adrenergic receptors differentially modulate antidepressant-like behavior in the mouse. Brain Res. 2009;1285:148-157. DOI 10.1016/j.brainres.2009.06.035.

7. Ellenbroek B.A., Geyer M.A., Cools A.R. The behavior of APO-SUS rats in animal models with construct validity for schizophrenia. J. Neurosci. 1995;15(11):7604-7611. DOI 0270-6474/95/157604-08$05.00/O.

8. Hoffman H.S., Wible B.L. Role of weak signals in acoustic startle. J. Acoust. Soc. Am. 1970;47:489-497. DOI 10.1121/1.1911919.

9. Hohnadel E., Bouchard K., Terry A.V. Galantamine and donepezil attenuate pharmacologically induced deficits in prepulse inhibition in rats. Neuropharmacology. 2007;52(2):542-551. DOI 10.1016/j.neu-ropharm.2006.08.025.

10. Joober R., Boksa P., Benkelfat C., Rouleau G. Genetics of schizophrenia: from animal models to clinical studies. J. Psychiatry Neurosci. 2002;27(5):336-347.

11. Kolpakov V.G., Kulikov A.V., Alekhina T.A., Chuguy V.F., Petrenko O.I., Barykina N.N. Catatonia or depression: The GC rat strain as an animal model of psychopathology. Genetika = Genetics (Moscow). 2004;40(6):827-834. DOI 10.1023/B:RUGE.0000033315.79449.d4. (in Russian)

12. Kvetnansky R., Sabban E.L., Palkovits M. Catecholaminergic systems in stress: structural and molecular genetic approaches. Physiol. Rev. 2009;89(2):535-606. DOI 10.1152/physrev.00042.2006.

13. Le Pen G., Moreau J.L. Disruption of prepulse inhibition of startle reflex in a neurodevelopmental model of schizophrenia: reversal by clozapine, olanzapine and risperidone but not by haloperidol. Neuropsychopharmacology. 2002;27(1):1-11. DOI 10.1016/S0893-133X(01)00383-9.

14. Lehmann J., Pryce C.R., Feldon J. Sex differences in the acoustic startle response and prepulse inhibition in Wistar rats. Behav. Brain Res. 1999;104(1-2):113-117. DOI 10.1016/S0166-4328(99)00058-3.

15. Li L., Du Y., Li N., Wu X., Wu Y. Top-down modulation of prepulse inhibition of the startle reflex in humans and rats. Neurosci. Biobehav. Rev. 2009;33(8):1157-1167. DOI 10.1016/j.neubiorev.2009.02.001.

16. Li L., Korngut L.M., Frost B.J., Beninger R.J. Prepulse inhibition following lesions of the inferior colliculus: prepulse intensity functions. Physiol. Behav. 1998;65(1):133-139. DOI 10.1016/S0031-9384(98)00143-7.

17. Martinez-Gras I., Rubio G., del Manzano B.A., Rodriguez-Jimenez R., Garcia-Sanchez F., Bagney A., Leza J.C., Borrell J. The relationship between prepulse inhibition and general psychopathology in patients with schizophrenia treated with long-acting risperidone. Schizophr. Res. 2009;115(2-3):215-221. DOI 10.1016/j.schres.2009.09.035.

18. Perry W., Minassian A., Lopez B., Maron L., Lincoln A. Sensorimotor gating deficits in adults with autism. Biol. Psychiatry. 2007;61(4): 482-486. DOI 10.1016/j.biopsych.2005.09.025.

19. Popova N.K., Barykina N.N., Alekhina T.A., Naumenko K.S., Kulikov A.V. Effects of 5-HT2-receptor blockade on the startle reflex and its prespulse inhibition in different mouse and rats strains. Ros-siyskiy fiziologicheskiy zhurnal im. I.M. Sechenova = I.M. Seche-nov Physiological Journal. 1999;85(6):857-864. (in Russian)

20. Powell S.B., Zhou X., Geyer M.A. Prepulse inhibition and genetic mouse models of schizophrenia. Behav. Brain Res. 2009;204(2):282-294. DOI 10.1016/j.bbr.2009.04.021.

21. Rohleder C., Jung F., Mertgens H., Wiedermann D., Sue M., Neumaier B., Graf R., Leweke F.M., Endepols H. Neural correlates of sensorimotor gating: a metabolic positron emission tomography study in awake rats. Front. Behav. Neurosci. 2014;8:178. DOI 10.3389/fnbeh.2014.00178.

22. Ryazanova M.A., Fedoseeva L.A., Ershov N.I., Efimov V.M., Mar-kel A.L., Redina O.E. The gene-expression profile of renal medulla in ISIAH rats with inherited stress-induced arterial hypertension. BMC Genet. 2016;17(3):166-173. DOI 10.1186/s12863-016-0462-6.

23. Ryazanova M.A., Igonina T.N., Alekhina T.A., Prokudina O.I. The increase in the proportion of nervous animals among those bred for catatonia: The participation of central adrenergic receptors in catatonic reactions. Genetika = Genetics (Moscow). 2012;48(11):1-8. DOI 10.1134/S1022795412100092. (in Russian)

24. Shishkina G.T., Kalinina T.S., Popova N.K., Dygalo N.N. Influence of neonatal short-term reduction in brainstem alpha2A-adrenergic receptors on receptor ontogenesis, acoustic startle reflex, and prepulse inhibition in rats. Behav. Neurosci. 2004;118(6):1285-1292. DOI 10.1037/0735-7044.118.6.1285.

25. Stone E.A., Grunewald G.L., Lin Y., Ahsan R., Rosengarten H., Kramer H.K., Quartermain D. Role of epinephrine stimulation of CNS al-adrenoceptors in motor activity in mice. Synapse. 2003a;49:67-76. DOI 10.1002/syn.10212.

26. Stone E.A., Lin Y., Quartermain D. Immobility from administration of the al-adrenergic antagonist, terazosin, in the IVth ventricle in rats. Neurosci. Lett. 2003b;353:231-233. DOI 10.1016/j.neulet. 2003.09.033.

27. Stone E.A., Quartermain D. Alpha-1-noradrenergic neurotransmission, corticosterone, and behavioral depression. Biol. Psychiatry. 1999; 46:1287-1300. DOI 10.1016/S0006-3223(99)00234-6.

28. Stone E.A., Zhang Y., Rosengarten H., Yeretsian J., Quartermain D. Brain alpha 1-adrenergic neurotransmission is necessary for behavioral activation to environmental change in mice. Neuroscince. 1999;94:1245-1252. DOI 10.1016/S0306-4522(99)00394-2.

29. Swerdlow N.R., Light G.A., Trim R.S., Breier M.R., Hines S.R., Powell S.B. Forebrain gene expression predicts deficits in sensorimotor gating after isolation rearing in male rats. Behav. Brain Res. 2013; 257:118-128. DOI 10.1016/j.bbr.2013.09.005.

30. Swerdlow N.R., Braff D.L., Taaid N., Geyer M.A. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. ArchGen Psychiatry. 1994;51(2):139-154. DOI 10.1001/archpsyc.1994.03950020063007.

31. Swerdlow N.R., Shilling P.D., Breier M. Trim R.S., Light G.A., Marie R.S. Fronto-temporal-mesolimbic gene expression and heritable differences in amphetamine-disrupted sensorimotor gating in rats. Psychopharmacology. 2012;224(3):349-362. DOI 10.1007/s00213-012-2758-1.

32. Swerdlow N.R., Weber M., Qu Y., Light G.A., Braff D.L. Realistic expectations of prepulse inhibition in translational models for schizophrenia research. Psychopharmacology. 2008;199(3):331-388. DOI 10.1007/s00213-008-1072-4.

33. Weber M., Chang W.L., Breier M.R., Yang A., Millan M.J., Swerd-low N.R. The effects of the dopamine D2 agonist sumanirole on prepulse inhibition in rats. Eur. Neuropsychopharmacol. 2010;20(6): 421-425. DOI 10.1016/j.euroneuro.2010.02.011.

34. Yeomans J.S., Lee J., Yeomans M.H., Steidl S., Li L. Midbrain pathways for prepulse inhibition and startle activation in rat. Neuroscience. 2006;142(4):921-929. DOI 10.1016/j.neuroscience.2006.06.025.